Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Seattle-Area Biotech Led by Ex-Athira CEO Leen Kawas Raises $35M for Hepatitis D Drug

Summary by GeekWire
EIT Pharma CEO Leen Kawas (EIT Pharma Photo) A Kirkland, Wash.-based biotech company led by former Athira Pharma CEO Leen Kawas has raised $35 million in

2 Articles

GeekWireGeekWire
Center

Seattle-area biotech led by ex-Athira CEO Leen Kawas raises $35M for hepatitis D drug

EIT Pharma CEO Leen Kawas (EIT Pharma Photo) A Kirkland, Wash.-based biotech company led by former Athira Pharma CEO Leen Kawas has raised $35 million in

·Seattle, United States
Read Full Article
citybizcitybiz

EIT Pharma Raises $35 Million Series A to Advance Lonafarnib

EIT Pharma has closed an oversubscribed $35 million Series A financing led by Propel Bio Partners, providing capital to advance... The post EIT Pharma Raises $35 Million Series A to Advance Lonafarnib appeared first on citybiz.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

citybiz broke the news on Monday, August 31, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Technology icon

Technology

Kirkland, Washington icon

Kirkland, Washington

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal